Review



apoa1 mimetics  (Mimetics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Mimetics apoa1 mimetics
    Apoa1 Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/apoa+i+mimetics/pmc13208257-15-4-5
    Average 86 stars, based on 1 article reviews
    apoa1 mimetics - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Analogues:

    Article Title: Therapeutic combinations to treat red blood cell disorders
    Article Snippet: .. In particular, LCAT activators, CETP inhibitors and modulators, ApoA1 mimetics, full-length ApoA1, ApoA1-mimetic peptides such as 5A, D-4F, L-4F, FAMP such as described in Uehara et al., 2015, Circ J, 79(12), 2523-8 and analogues, reconstituted HDL, including ApoA1-phospholipid complexes, ApoA1 Milano, ApoE phospholipid complexes are considered as HDL enhancers. ..

    Article Title: Therapeutic combinations to treat red blood cell disorders
    Article Snippet: .. Therefore, ApoA1 mimetics, full-length ApoA1, ApoA1-mimetic peptides such as D-4F, L-4F, FAMP and analogues may be used as agents capable of enhancing the HDL activity according to the invention. ..

    other:

    Article Title: Therapeutic combinations to treat red blood cell disorders
    Article Snippet: ApoA1 mimetics and/or full-length ApoA1 adequately formulated (U.S. Pat.

    Article Title: Apolipoprotein A1 Gene Polymorphism and Its Association With TNF-Alpha and Interleukin-6 Levels in Uncomplicated Plasmodium Falciparum Malaria in Nigerian Children
    Article Snippet: Finally, studies on APOA1 mimetics or other anti-inflammatory interventions could pave the way for novel therapeutic strategies to improve malaria outcomes.

    Activity Assay:

    Article Title: Therapeutic combinations to treat red blood cell disorders
    Article Snippet: .. Therefore, ApoA1 mimetics, full-length ApoA1, ApoA1-mimetic peptides such as D-4F, L-4F, FAMP and analogues may be used as agents capable of enhancing the HDL activity according to the invention. ..



    Similar Products

    apoa1 mimetics  (Mimetics)
    86
    Mimetics apoa1 mimetics
    Apoa1 Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/apoa+i+mimetics/pmc13208257-15-4-5
    Average 86 stars, based on 1 article reviews
    apoa1 mimetics - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    apoa1 mimetics m2 m1 macrophage repolarization  (Mimetics)
    86
    Mimetics apoa1 mimetics m2 m1 macrophage repolarization
    Apoa1 Mimetics M2 M1 Macrophage Repolarization, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/apoa+i+mimetics/pmc13039540-153-0-1
    Average 86 stars, based on 1 article reviews
    apoa1 mimetics m2 m1 macrophage repolarization - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    apoa1 mimetic peptide 4 f  (Dawley Inc)
    86
    Dawley Inc apoa1 mimetic peptide 4 f
    Mechanism by which <t>ApoA1</t> Inhibits Vascular Endothelial Inflammation. Lipid-free ApoA1 protein or its mimetic peptides interact with the ABCA1 receptor (a 12-transmembrane protein located in non-raft membrane domains, which has poor cholesterol) on macrophages. Concurrently, ApoA1 within (r)HDL interacts with the scavenger receptor SR-B1 (located in cholesterol-rich lipid raft domains). Both interactions promote the efflux of free cholesterol from macrophages to ApoA1 (indicated by a yellow straight arrow). Notably, the cholesterol efflux regulatory protein AIBP (ApoA1-Binding Protein) enhances the binding of ApoA1 to the ABCA1 receptor. Pathway ①: Inhibition of TLR4 consequently suppresses its downstream pro-inflammatory signaling pathways. Pathways ② and ③: Signaling pathways that inhibit inflammation, initiated respectively by the binding of ApoA1 to the ABCA1 receptor and HDL to the SR-B1 receptor. Pathway ④: Reconstituted HDL (rHDL) inhibits LPS-stimulated activation of the NLRP3 inflammasome. Created with BioGDP.com
    Apoa1 Mimetic Peptide 4 F, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/4+apoa1+f+mimetic+peptide/pmc12506352-15-0-11
    Average 86 stars, based on 1 article reviews
    apoa1 mimetic peptide 4 f - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    apoa1 mimetic peptide (22a)  (GenScript corporation)
    90
    GenScript corporation apoa1 mimetic peptide (22a)
    Mechanism by which <t>ApoA1</t> Inhibits Vascular Endothelial Inflammation. Lipid-free ApoA1 protein or its mimetic peptides interact with the ABCA1 receptor (a 12-transmembrane protein located in non-raft membrane domains, which has poor cholesterol) on macrophages. Concurrently, ApoA1 within (r)HDL interacts with the scavenger receptor SR-B1 (located in cholesterol-rich lipid raft domains). Both interactions promote the efflux of free cholesterol from macrophages to ApoA1 (indicated by a yellow straight arrow). Notably, the cholesterol efflux regulatory protein AIBP (ApoA1-Binding Protein) enhances the binding of ApoA1 to the ABCA1 receptor. Pathway ①: Inhibition of TLR4 consequently suppresses its downstream pro-inflammatory signaling pathways. Pathways ② and ③: Signaling pathways that inhibit inflammation, initiated respectively by the binding of ApoA1 to the ABCA1 receptor and HDL to the SR-B1 receptor. Pathway ④: Reconstituted HDL (rHDL) inhibits LPS-stimulated activation of the NLRP3 inflammasome. Created with BioGDP.com
    Apoa1 Mimetic Peptide (22a), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/apoa1+mimetic+peptide++22a+/us12257352-1434-0-27
    Average 90 stars, based on 1 article reviews
    apoa1 mimetic peptide (22a) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    apolipoprotein a1-mimetic peptide (apoa1, pvldlfrellnellealkqklk, pk-22)  (Shanghai Apeptide Co)
    90
    Shanghai Apeptide Co apolipoprotein a1-mimetic peptide (apoa1, pvldlfrellnellealkqklk, pk-22)
    Mechanism by which <t>ApoA1</t> Inhibits Vascular Endothelial Inflammation. Lipid-free ApoA1 protein or its mimetic peptides interact with the ABCA1 receptor (a 12-transmembrane protein located in non-raft membrane domains, which has poor cholesterol) on macrophages. Concurrently, ApoA1 within (r)HDL interacts with the scavenger receptor SR-B1 (located in cholesterol-rich lipid raft domains). Both interactions promote the efflux of free cholesterol from macrophages to ApoA1 (indicated by a yellow straight arrow). Notably, the cholesterol efflux regulatory protein AIBP (ApoA1-Binding Protein) enhances the binding of ApoA1 to the ABCA1 receptor. Pathway ①: Inhibition of TLR4 consequently suppresses its downstream pro-inflammatory signaling pathways. Pathways ② and ③: Signaling pathways that inhibit inflammation, initiated respectively by the binding of ApoA1 to the ABCA1 receptor and HDL to the SR-B1 receptor. Pathway ④: Reconstituted HDL (rHDL) inhibits LPS-stimulated activation of the NLRP3 inflammasome. Created with BioGDP.com
    Apolipoprotein A1 Mimetic Peptide (Apoa1, Pvldlfrellnellealkqklk, Pk 22), supplied by Shanghai Apeptide Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apoa1+mimetics/r4f++an+apoa1+mimetic+peptide++ac+faekfkeavkdyfakfwd+/pm40106687__nl4c06402_si_001-7-1-11
    Average 90 stars, based on 1 article reviews
    apolipoprotein a1-mimetic peptide (apoa1, pvldlfrellnellealkqklk, pk-22) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Mechanism by which ApoA1 Inhibits Vascular Endothelial Inflammation. Lipid-free ApoA1 protein or its mimetic peptides interact with the ABCA1 receptor (a 12-transmembrane protein located in non-raft membrane domains, which has poor cholesterol) on macrophages. Concurrently, ApoA1 within (r)HDL interacts with the scavenger receptor SR-B1 (located in cholesterol-rich lipid raft domains). Both interactions promote the efflux of free cholesterol from macrophages to ApoA1 (indicated by a yellow straight arrow). Notably, the cholesterol efflux regulatory protein AIBP (ApoA1-Binding Protein) enhances the binding of ApoA1 to the ABCA1 receptor. Pathway ①: Inhibition of TLR4 consequently suppresses its downstream pro-inflammatory signaling pathways. Pathways ② and ③: Signaling pathways that inhibit inflammation, initiated respectively by the binding of ApoA1 to the ABCA1 receptor and HDL to the SR-B1 receptor. Pathway ④: Reconstituted HDL (rHDL) inhibits LPS-stimulated activation of the NLRP3 inflammasome. Created with BioGDP.com

    Journal: Critical Care

    Article Title: ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review

    doi: 10.1186/s13054-025-05668-1

    Figure Lengend Snippet: Mechanism by which ApoA1 Inhibits Vascular Endothelial Inflammation. Lipid-free ApoA1 protein or its mimetic peptides interact with the ABCA1 receptor (a 12-transmembrane protein located in non-raft membrane domains, which has poor cholesterol) on macrophages. Concurrently, ApoA1 within (r)HDL interacts with the scavenger receptor SR-B1 (located in cholesterol-rich lipid raft domains). Both interactions promote the efflux of free cholesterol from macrophages to ApoA1 (indicated by a yellow straight arrow). Notably, the cholesterol efflux regulatory protein AIBP (ApoA1-Binding Protein) enhances the binding of ApoA1 to the ABCA1 receptor. Pathway ①: Inhibition of TLR4 consequently suppresses its downstream pro-inflammatory signaling pathways. Pathways ② and ③: Signaling pathways that inhibit inflammation, initiated respectively by the binding of ApoA1 to the ABCA1 receptor and HDL to the SR-B1 receptor. Pathway ④: Reconstituted HDL (rHDL) inhibits LPS-stimulated activation of the NLRP3 inflammasome. Created with BioGDP.com

    Article Snippet: APOA1 mimetic peptide 4 F , In vivo , Sprague - Dawley rats , 10 mg/kg; i.p. , CLP , , IL-6↓;HDL↑; survival rate↑ , [ ] .

    Techniques: Membrane, Binding Assay, Inhibition, Protein-Protein interactions, Activation Assay

    ApoA1 maintains endothelial barrier integrity. Pathway ①: ApoA1 and ApoA1 mimetic peptides (such as D-4 F) inhibit EndMT in endothelial cells. Pathway ②: (r)HDL binds to the SR-B1 receptor, initiating signaling pathways that upregulate ANGPTL4 levels, thereby protecting the endothelial glycocalyx. Created with BioGDP.com

    Journal: Critical Care

    Article Title: ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review

    doi: 10.1186/s13054-025-05668-1

    Figure Lengend Snippet: ApoA1 maintains endothelial barrier integrity. Pathway ①: ApoA1 and ApoA1 mimetic peptides (such as D-4 F) inhibit EndMT in endothelial cells. Pathway ②: (r)HDL binds to the SR-B1 receptor, initiating signaling pathways that upregulate ANGPTL4 levels, thereby protecting the endothelial glycocalyx. Created with BioGDP.com

    Article Snippet: APOA1 mimetic peptide 4 F , In vivo , Sprague - Dawley rats , 10 mg/kg; i.p. , CLP , , IL-6↓;HDL↑; survival rate↑ , [ ] .

    Techniques: Protein-Protein interactions

    ApoA1 prevents vascular occlusion, thrombosis, and maintains vascular tone. Pathway ①: (r)HDL binds to the PDZK1 domain of SR-B1, leading to eNOS phosphorylation, producing NO to prevent microvascular occlusion and reducing vWF. Pathway ②: Lipid-free ApoA1 or (r)HDL binds to Ecto-F1-ATPase, activating the PI3Kβ/AKT signaling pathway. Pathway ③ and ④ upregulate COX-2 and PGI-2. Created with BioGDP.com

    Journal: Critical Care

    Article Title: ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review

    doi: 10.1186/s13054-025-05668-1

    Figure Lengend Snippet: ApoA1 prevents vascular occlusion, thrombosis, and maintains vascular tone. Pathway ①: (r)HDL binds to the PDZK1 domain of SR-B1, leading to eNOS phosphorylation, producing NO to prevent microvascular occlusion and reducing vWF. Pathway ②: Lipid-free ApoA1 or (r)HDL binds to Ecto-F1-ATPase, activating the PI3Kβ/AKT signaling pathway. Pathway ③ and ④ upregulate COX-2 and PGI-2. Created with BioGDP.com

    Article Snippet: APOA1 mimetic peptide 4 F , In vivo , Sprague - Dawley rats , 10 mg/kg; i.p. , CLP , , IL-6↓;HDL↑; survival rate↑ , [ ] .

    Techniques: Phospho-proteomics